Latest News for JCRRF
HYOGO, Japan--(BUSINESS WIRE)--JCR announced the presentation of four datasets demonstrating the potential benefits of its investigational therapies at the WORLDSymposium 2026.
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals announced that it will present data at the 22nd Annual WORLDSymposium 2026, held February 2-6, 2026, in San Diego, Calif.
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference taking place January 12–15, 2026.
MILAN & HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals and Italfarmaco announced an exclusive licensing agreement for the development and commercialization of givinostat in Japan.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for JCRRF.
Senate Trading
No Senate trades found for JCRRF.
U.S. House Trading
No House trades found for JCRRF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.